Literature DB >> 9475509

Comparative modulation by 3 alpha,5 alpha and 3 beta,5 beta neurosteroids of GABA binding sites during avian central nervous system development.

M S Viapiano1, S Fiszer de Plazas.   

Abstract

Neurosteroids are endogenous Central Nervous System (CNS) compounds which act mainly by allosteric modulation of the GABAA receptor complex. The presence of a 3 alpha-hydroxyl group and a 5 alpha-hydrogen atom have been found to be essential structural requirements for biological activity in mammals. In the present work we report the enhancing activity on [3H]GABA binding to its receptor sites in chick optic lobe produced by progesterone metabolites 3 alpha-hydroxy,5 alpha-pregnan-20-one (3 alpha,5 alpha-P) and 3 beta-hydroxy,5 beta-pregnan-20-one (3 beta,5 beta-P). Both steroids were found able to enhance [3H]GABA binding along ontogeny, displaying a similar profile at early developmental stages, while in adulthood 3 alpha,5 alpha-P had greater potency (EC50 0.22 microM) and enhancing effect (Emax: 122%). In adult synaptic membranes, the two compounds displayed a complex interaction with the GABAA receptor, disclosed by a Schild plot with slope below one and an incomplete displacement of 3 alpha,5 alpha-P by its 3 beta,5 beta isomer. Such complexity could be related to the steroidogenic profile in avian CNS, with 5 alpha-reduced progesterone metabolites present since early development, while 3 alpha,5 alpha-P is found only in adulthood. Bearing in mind differences between avian and mammalian steroidogenic profiles and the relevance of 5 beta-steroids in early avian development, we propose that 3 beta,5 beta-P, instead of the classical potent 3 alpha,5 alpha-steroids, may be the endogenous modulator of GABAergic activity in developing avian brain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9475509     DOI: 10.1023/a:1022472623472

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  35 in total

Review 1.  Molecular mechanisms in the receptor action of benzodiazepines.

Authors:  E Costa; A Guidotti
Journal:  Annu Rev Pharmacol Toxicol       Date:  1979       Impact factor: 13.820

2.  Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor.

Authors:  M D Majewska; N L Harrison; R D Schwartz; J L Barker; S M Paul
Journal:  Science       Date:  1986-05-23       Impact factor: 47.728

3.  Pentobarbital modulatory effect on GABA binding sites in developing chick optic lobe.

Authors:  S Fiszer de Plazas; M S Viapiano; A Mitridate de Novara
Journal:  Int J Dev Neurosci       Date:  1995-12       Impact factor: 2.457

4.  The biosynthesis of adrenal steroids by the 15-day-old chick embryo.

Authors:  E A Pedernera; C P Lantos
Journal:  Gen Comp Endocrinol       Date:  1973-04       Impact factor: 2.822

5.  Stimulation of GABA receptor binding by barbiturates.

Authors:  T Asano; N Ogasawara
Journal:  Eur J Pharmacol       Date:  1982-02-05       Impact factor: 4.432

Review 6.  Neurosteroids: a new brain function?

Authors:  E E Baulieu; P Robel
Journal:  J Steroid Biochem Mol Biol       Date:  1990-11-20       Impact factor: 4.292

7.  Progesterone and its reductive metabolism in steroidogenic tissues of the developing hen embryo.

Authors:  C B Gonzalez; E N Cozza; M E De Bedners; C P Lantos; A Aragones
Journal:  Gen Comp Endocrinol       Date:  1983-09       Impact factor: 2.822

8.  Differential antagonism by epipregnanolone of alphaxalone and pregnanolone potentiation of [3H]flunitrazepam binding suggests more than one class of binding site for steroids at GABAA receptors.

Authors:  R J Prince; M A Simmonds
Journal:  Neuropharmacology       Date:  1993-01       Impact factor: 5.250

9.  Enhancement of GABA binding by benzodiazepines and related anxiolytics.

Authors:  J H Skerritt; G A Johnston
Journal:  Eur J Pharmacol       Date:  1983-05-06       Impact factor: 4.432

10.  Modulation of the GABAA receptor by depressant barbiturates and pregnane steroids.

Authors:  J A Peters; E F Kirkness; H Callachan; J J Lambert; A J Turner
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.